Cargando…
Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer
BACKGROUND: Epigenetic alterations have been implicated in the pathogenesis of solid tumors, however, proto-oncogenes activated by promoter demethylation have been sporadically reported. We used an integrative method to analyze expression in primary head and neck squamous cell carcinoma (HNSCC) and...
Autores principales: | Smith, Ian M., Glazer, Chad A., Mithani, Suhail K., Ochs, Michael F., Sun, Wenyue, Bhan, Sheetal, Vostrov, Alexander, Abdullaev, Ziedulla, Lobanenkov, Victor, Gray, Andrew, Liu, Chunyan, Chang, Steven S., Ostrow, Kimberly L., Westra, William H., Begum, Shahnaz, Dhara, Mousumi, Califano, Joseph |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654921/ https://www.ncbi.nlm.nih.gov/pubmed/19305507 http://dx.doi.org/10.1371/journal.pone.0004961 |
Ejemplares similares
-
Integrative Discovery of Epigenetically Derepressed Cancer Testis Antigens in NSCLC
por: Glazer, Chad A., et al.
Publicado: (2009) -
Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors
por: Renaud, Stéphanie, et al.
Publicado: (2007) -
MAGEB2 is Activated by Promoter Demethylation in Head and Neck Squamous Cell Carcinoma
por: Pattani, Kavita M., et al.
Publicado: (2012) -
Demethylating Agents in the Treatment of Cancer
por: Howell, Paul M., et al.
Publicado: (2010) -
Dose-Dependent Activation of Putative Oncogene SBSN by BORIS
por: Gaykalova, Daria, et al.
Publicado: (2012)